Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes

Laura M. Raffield, Gretchen A. Brenes, Amanda J. Cox, Barry I. Freedman, Christina E. Hugenschmidt, Fang Chi Hsu, Jianzhao Xu, Benjamin C. Wagner, Jeff D. Williamson, Joseph A Maldjian, Donald W. Bowden

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims Anxiety, depression, accelerated cognitive decline, and increased risk of dementia are observed in individuals with type 2 diabetes. Anxiety and depression may contribute to lower performance on cognitive tests and differences in neuroimaging observed in individuals with type 2 diabetes. Methods These relationships were assessed in 655 European Americans with type 2 diabetes from 504 Diabetes Heart Study families. Participants completed cognitive testing, brain magnetic resonance imaging, the Brief Symptom Inventory Anxiety subscale, and the Center for Epidemiologic Studies Depression-10. Results In analyses adjusted for age, sex, educational attainment, and use of psychotropic medications, individuals with comorbid anxiety and depression symptoms had lower performance on all cognitive testing measures assessed (p ≤ 0.005). Those with both anxiety and depression also had increased white matter lesion volume (p = 0.015), decreased gray matter cerebral blood flow (p = 4.43 10- 6), decreased gray matter volume (p = 0.002), increased white and gray matter mean diffusivity (p ≤ 0.001), and decreased white matter fractional anisotropy (p = 7.79 × 10- 4). These associations were somewhat attenuated upon further adjustment for health status related covariates. Conclusions Comorbid anxiety and depression symptoms were associated with cognitive performance and brain structure in a European American cohort with type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)143-149
Number of pages7
JournalJournal of Diabetes and its Complications
Volume30
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Neurobehavioral Manifestations
Neuroimaging
Type 2 Diabetes Mellitus
Anxiety
Depression
Cerebrovascular Circulation
Anisotropy
Brain
Health Status
Dementia
Epidemiologic Studies
Magnetic Resonance Imaging
Equipment and Supplies
White Matter
Gray Matter

Keywords

  • Anxiety
  • Cognition
  • Depression
  • Magnetic resonance imaging
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Raffield, L. M., Brenes, G. A., Cox, A. J., Freedman, B. I., Hugenschmidt, C. E., Hsu, F. C., ... Bowden, D. W. (2016). Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes. Journal of Diabetes and its Complications, 30(1), 143-149. https://doi.org/10.1016/j.jdiacomp.2015.09.010

Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes. / Raffield, Laura M.; Brenes, Gretchen A.; Cox, Amanda J.; Freedman, Barry I.; Hugenschmidt, Christina E.; Hsu, Fang Chi; Xu, Jianzhao; Wagner, Benjamin C.; Williamson, Jeff D.; Maldjian, Joseph A; Bowden, Donald W.

In: Journal of Diabetes and its Complications, Vol. 30, No. 1, 01.01.2016, p. 143-149.

Research output: Contribution to journalArticle

Raffield, LM, Brenes, GA, Cox, AJ, Freedman, BI, Hugenschmidt, CE, Hsu, FC, Xu, J, Wagner, BC, Williamson, JD, Maldjian, JA & Bowden, DW 2016, 'Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes', Journal of Diabetes and its Complications, vol. 30, no. 1, pp. 143-149. https://doi.org/10.1016/j.jdiacomp.2015.09.010
Raffield, Laura M. ; Brenes, Gretchen A. ; Cox, Amanda J. ; Freedman, Barry I. ; Hugenschmidt, Christina E. ; Hsu, Fang Chi ; Xu, Jianzhao ; Wagner, Benjamin C. ; Williamson, Jeff D. ; Maldjian, Joseph A ; Bowden, Donald W. / Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes. In: Journal of Diabetes and its Complications. 2016 ; Vol. 30, No. 1. pp. 143-149.
@article{7d954f1fa8834a8aa01d7cdcee3a9635,
title = "Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes",
abstract = "Aims Anxiety, depression, accelerated cognitive decline, and increased risk of dementia are observed in individuals with type 2 diabetes. Anxiety and depression may contribute to lower performance on cognitive tests and differences in neuroimaging observed in individuals with type 2 diabetes. Methods These relationships were assessed in 655 European Americans with type 2 diabetes from 504 Diabetes Heart Study families. Participants completed cognitive testing, brain magnetic resonance imaging, the Brief Symptom Inventory Anxiety subscale, and the Center for Epidemiologic Studies Depression-10. Results In analyses adjusted for age, sex, educational attainment, and use of psychotropic medications, individuals with comorbid anxiety and depression symptoms had lower performance on all cognitive testing measures assessed (p ≤ 0.005). Those with both anxiety and depression also had increased white matter lesion volume (p = 0.015), decreased gray matter cerebral blood flow (p = 4.43 10- 6), decreased gray matter volume (p = 0.002), increased white and gray matter mean diffusivity (p ≤ 0.001), and decreased white matter fractional anisotropy (p = 7.79 × 10- 4). These associations were somewhat attenuated upon further adjustment for health status related covariates. Conclusions Comorbid anxiety and depression symptoms were associated with cognitive performance and brain structure in a European American cohort with type 2 diabetes.",
keywords = "Anxiety, Cognition, Depression, Magnetic resonance imaging, Type 2 diabetes",
author = "Raffield, {Laura M.} and Brenes, {Gretchen A.} and Cox, {Amanda J.} and Freedman, {Barry I.} and Hugenschmidt, {Christina E.} and Hsu, {Fang Chi} and Jianzhao Xu and Wagner, {Benjamin C.} and Williamson, {Jeff D.} and Maldjian, {Joseph A} and Bowden, {Donald W.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.jdiacomp.2015.09.010",
language = "English (US)",
volume = "30",
pages = "143--149",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes

AU - Raffield, Laura M.

AU - Brenes, Gretchen A.

AU - Cox, Amanda J.

AU - Freedman, Barry I.

AU - Hugenschmidt, Christina E.

AU - Hsu, Fang Chi

AU - Xu, Jianzhao

AU - Wagner, Benjamin C.

AU - Williamson, Jeff D.

AU - Maldjian, Joseph A

AU - Bowden, Donald W.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Aims Anxiety, depression, accelerated cognitive decline, and increased risk of dementia are observed in individuals with type 2 diabetes. Anxiety and depression may contribute to lower performance on cognitive tests and differences in neuroimaging observed in individuals with type 2 diabetes. Methods These relationships were assessed in 655 European Americans with type 2 diabetes from 504 Diabetes Heart Study families. Participants completed cognitive testing, brain magnetic resonance imaging, the Brief Symptom Inventory Anxiety subscale, and the Center for Epidemiologic Studies Depression-10. Results In analyses adjusted for age, sex, educational attainment, and use of psychotropic medications, individuals with comorbid anxiety and depression symptoms had lower performance on all cognitive testing measures assessed (p ≤ 0.005). Those with both anxiety and depression also had increased white matter lesion volume (p = 0.015), decreased gray matter cerebral blood flow (p = 4.43 10- 6), decreased gray matter volume (p = 0.002), increased white and gray matter mean diffusivity (p ≤ 0.001), and decreased white matter fractional anisotropy (p = 7.79 × 10- 4). These associations were somewhat attenuated upon further adjustment for health status related covariates. Conclusions Comorbid anxiety and depression symptoms were associated with cognitive performance and brain structure in a European American cohort with type 2 diabetes.

AB - Aims Anxiety, depression, accelerated cognitive decline, and increased risk of dementia are observed in individuals with type 2 diabetes. Anxiety and depression may contribute to lower performance on cognitive tests and differences in neuroimaging observed in individuals with type 2 diabetes. Methods These relationships were assessed in 655 European Americans with type 2 diabetes from 504 Diabetes Heart Study families. Participants completed cognitive testing, brain magnetic resonance imaging, the Brief Symptom Inventory Anxiety subscale, and the Center for Epidemiologic Studies Depression-10. Results In analyses adjusted for age, sex, educational attainment, and use of psychotropic medications, individuals with comorbid anxiety and depression symptoms had lower performance on all cognitive testing measures assessed (p ≤ 0.005). Those with both anxiety and depression also had increased white matter lesion volume (p = 0.015), decreased gray matter cerebral blood flow (p = 4.43 10- 6), decreased gray matter volume (p = 0.002), increased white and gray matter mean diffusivity (p ≤ 0.001), and decreased white matter fractional anisotropy (p = 7.79 × 10- 4). These associations were somewhat attenuated upon further adjustment for health status related covariates. Conclusions Comorbid anxiety and depression symptoms were associated with cognitive performance and brain structure in a European American cohort with type 2 diabetes.

KW - Anxiety

KW - Cognition

KW - Depression

KW - Magnetic resonance imaging

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84951790588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951790588&partnerID=8YFLogxK

U2 - 10.1016/j.jdiacomp.2015.09.010

DO - 10.1016/j.jdiacomp.2015.09.010

M3 - Article

VL - 30

SP - 143

EP - 149

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 1

ER -